Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Por um escritor misterioso
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
AI Enabled Precision Medicine: Patient Stratification, Drug Repurposing and Combination Therapies
Fierce Biotech's 2022 Fierce 15
Small molecules, big impact: 20 years of targeted therapy in oncology - The Lancet
A precision medicine–based, 'fast-fail' approach for psychiatry
AI Drug Discovery: Key Trends and Developments in Pharma Industry
Frontiers MicroRNA as an Important Target for Anticancer Drug Development
Cancers, Free Full-Text
Harnessing the modified proteome for increased diagnostic power - Drug Discovery World (DDW)
Integration of personalized drug delivery systems into digital health - ScienceDirect
